Skip to main content
Erschienen in: International Journal of Hematology 2/2010

01.03.2010 | Original Article

Adult bone marrow cells can differentiate into hemopoietic cells and endothelial cells but not into other lineage cells in normal growth and normal life

verfasst von: Seiji Yanai, Yasushi Adachi, Ming Shi, Akio Shigematsu, Chieko Shima, Yuichiro Imai, A-Hon Kwon, Susumu Ikehara

Erschienen in: International Journal of Hematology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

There have been reports that bone marrow cells (BMCs) can differentiate into various cells and tissues and that BMCs improve the function of the injured organs or reduce the organ damage, thereby rescuing the individuals from death. However, these reports also noted that injuries were induced in the organs. Therefore, it is not clear whether BMCs can differentiate into parenchymal cells in organs in normal life or whether BMCs can supply organ-specific stem cells. In this paper, we examine whether adult BMCs could contribute to the development of various organs in normal development after birth and in normal life. BMCs from adult eGFP mice (8 weeks old) were injected into the liver of newborn C57BL/6 mice. The existence of donor-derived cells in various organs was examined 1 year after the injection. In the organs of recipient mice, some of the CD45+ hemopoietic cells (1.4–13.2%) and CD31+ endothelial cells (0–2.2%) expressed eGFP, though no other lineage cells did so. These results suggest that adult BMCs can differentiate into not only hemopoietic cells but also vascular endothelial cells, but cannot differentiate into other lineage cells in normal growth and normal life.
Literatur
1.
Zurück zum Zitat Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229–34.CrossRefPubMed Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229–34.CrossRefPubMed
2.
Zurück zum Zitat Theise ND, Badve S, Saxena R, et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology. 2000;31:235–40.CrossRefPubMed Theise ND, Badve S, Saxena R, et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology. 2000;31:235–40.CrossRefPubMed
3.
Zurück zum Zitat Díez M, Barberà JA, Ferrer E, et al. Plasticity of CD133 (+) cells: role in pulmonary vascular remodeling. Cardiovasc Res. 2007;76:517–27.CrossRefPubMed Díez M, Barberà JA, Ferrer E, et al. Plasticity of CD133 (+) cells: role in pulmonary vascular remodeling. Cardiovasc Res. 2007;76:517–27.CrossRefPubMed
4.
Zurück zum Zitat Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105:369–77.CrossRefPubMed Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105:369–77.CrossRefPubMed
5.
Zurück zum Zitat Goodell MA, Jackson KA, Majka SM, et al. Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci. 2001;938:208–20.PubMedCrossRef Goodell MA, Jackson KA, Majka SM, et al. Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci. 2001;938:208–20.PubMedCrossRef
6.
Zurück zum Zitat Rota M, Kajstura J, Hosoda T, et al. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci (USA). 2007;104:17783–8.CrossRef Rota M, Kajstura J, Hosoda T, et al. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci (USA). 2007;104:17783–8.CrossRef
7.
Zurück zum Zitat Fujiyama S, Amano K, Uehira K, et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res. 2003;93:980–99.CrossRefPubMed Fujiyama S, Amano K, Uehira K, et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res. 2003;93:980–99.CrossRefPubMed
8.
Zurück zum Zitat Lin CY, Lee BS, Liao CC, et al. Transdifferentiation of bone marrow stem cells into acinar cells using a double chamber system. J Formos Med Assoc. 2007;106:1–7.CrossRefPubMed Lin CY, Lee BS, Liao CC, et al. Transdifferentiation of bone marrow stem cells into acinar cells using a double chamber system. J Formos Med Assoc. 2007;106:1–7.CrossRefPubMed
9.
Zurück zum Zitat Hayashi Y, Tsuji S, Tsujii M, et al. The transdifferentiation of bone-marrow-derived cells in colonic mucosal regeneration after dextran-sulfate-sodium-induced colitis in mice. Pharmacology. 2007;80:193–9.CrossRefPubMed Hayashi Y, Tsuji S, Tsujii M, et al. The transdifferentiation of bone-marrow-derived cells in colonic mucosal regeneration after dextran-sulfate-sodium-induced colitis in mice. Pharmacology. 2007;80:193–9.CrossRefPubMed
10.
Zurück zum Zitat Krause DS. Engraftment of bone marrow-derived epithelial cells. Ann N Y Acad Sci. 2005;1044:117–24.CrossRefPubMed Krause DS. Engraftment of bone marrow-derived epithelial cells. Ann N Y Acad Sci. 2005;1044:117–24.CrossRefPubMed
11.
Zurück zum Zitat Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002;416(6880):542–5.CrossRefPubMed Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002;416(6880):542–5.CrossRefPubMed
12.
Zurück zum Zitat Jang YY, Collector MI, Baylin SB, et al. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol. 2004;6:532–9.CrossRefPubMed Jang YY, Collector MI, Baylin SB, et al. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol. 2004;6:532–9.CrossRefPubMed
13.
Zurück zum Zitat Minamino K, Adachi Y, Okigaki M, et al. Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization. Stem Cells. 2005;23:347–54.CrossRefPubMed Minamino K, Adachi Y, Okigaki M, et al. Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization. Stem Cells. 2005;23:347–54.CrossRefPubMed
14.
Zurück zum Zitat Iwasaki M, Adachi Y, Minamino K, et al. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J Am Soc Nephrol. 2005;16:658–66.CrossRefPubMed Iwasaki M, Adachi Y, Minamino K, et al. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J Am Soc Nephrol. 2005;16:658–66.CrossRefPubMed
15.
Zurück zum Zitat Tomita M, Adachi Y, Yamada H, et al. Bone marrow-derived stem cells can differentiate into retinal cells in injured rat retina. Stem Cells. 2002;20:279–83.CrossRefPubMed Tomita M, Adachi Y, Yamada H, et al. Bone marrow-derived stem cells can differentiate into retinal cells in injured rat retina. Stem Cells. 2002;20:279–83.CrossRefPubMed
16.
Zurück zum Zitat Minamino K, Adachi Y, Yamada H, et al. Long-term survival of bone marrow-derived retinal nerve cells in the retina. Neuroreport. 2005;16:1255–9.CrossRefPubMed Minamino K, Adachi Y, Yamada H, et al. Long-term survival of bone marrow-derived retinal nerve cells in the retina. Neuroreport. 2005;16:1255–9.CrossRefPubMed
17.
Zurück zum Zitat Zen K, Okigaki M, Hosokawa Y, et al. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J Mol Cell Cardiol. 2006;40:799–809.CrossRefPubMed Zen K, Okigaki M, Hosokawa Y, et al. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J Mol Cell Cardiol. 2006;40:799–809.CrossRefPubMed
18.
Zurück zum Zitat Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701–5.CrossRefPubMed Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701–5.CrossRefPubMed
19.
Zurück zum Zitat Ishikawa T, Terai S, Urata Y, et al. Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes. Cell Tissue Res. 2006;323:221–31.CrossRefPubMed Ishikawa T, Terai S, Urata Y, et al. Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes. Cell Tissue Res. 2006;323:221–31.CrossRefPubMed
20.
Zurück zum Zitat Okabe M, Ikawa M, Kominami K, et al. ‘Green mice’ as a source of ubiquitous green cells. FEBS Lett. 1997;407:313–9.CrossRefPubMed Okabe M, Ikawa M, Kominami K, et al. ‘Green mice’ as a source of ubiquitous green cells. FEBS Lett. 1997;407:313–9.CrossRefPubMed
21.
Zurück zum Zitat Nakano K, Adachi Y, Minamino K, et al. Mechanisms underlying acceleration of blood flow recovery in ischemic limbs by macrophage colony-stimulating factor (M-CSF). Stem Cells. 2006;24:1274–9.CrossRefPubMed Nakano K, Adachi Y, Minamino K, et al. Mechanisms underlying acceleration of blood flow recovery in ischemic limbs by macrophage colony-stimulating factor (M-CSF). Stem Cells. 2006;24:1274–9.CrossRefPubMed
22.
Zurück zum Zitat Imada T, Tatsumi T, Mori Y, et al. Targeted delivery of bone marrow mononuclear cells by ultrasound destruction of microbubbles induces both angiogenesis and arteriogenesis response. Arterioscler Thromb Vasc Biol. 2005;25:2128–34.CrossRefPubMed Imada T, Tatsumi T, Mori Y, et al. Targeted delivery of bone marrow mononuclear cells by ultrasound destruction of microbubbles induces both angiogenesis and arteriogenesis response. Arterioscler Thromb Vasc Biol. 2005;25:2128–34.CrossRefPubMed
23.
Zurück zum Zitat Wang X, Ge S, Gonzalez I, et al. Formation of pancreatic duct epithelium from bone marrow during neonatal development. Stem Cells. 2006;24:307–14.CrossRefPubMed Wang X, Ge S, Gonzalez I, et al. Formation of pancreatic duct epithelium from bone marrow during neonatal development. Stem Cells. 2006;24:307–14.CrossRefPubMed
24.
Zurück zum Zitat Bjerknes M, Cheng H. Clonal analysis of mouse intestinal epithelial progenitors. Gastroenterology. 1999;116:7–14.CrossRefPubMed Bjerknes M, Cheng H. Clonal analysis of mouse intestinal epithelial progenitors. Gastroenterology. 1999;116:7–14.CrossRefPubMed
25.
Zurück zum Zitat Rizvi AZ, Swain JR, et al. Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci USA. 2006;103:6321–5.CrossRefPubMed Rizvi AZ, Swain JR, et al. Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci USA. 2006;103:6321–5.CrossRefPubMed
26.
Zurück zum Zitat Rountree CB, Wang X, Ge S, et al. Bone marrow fails to differentiate into liver epithelium during murine development and regeneration. Hepatology. 2007;45:1250–60.CrossRefPubMed Rountree CB, Wang X, Ge S, et al. Bone marrow fails to differentiate into liver epithelium during murine development and regeneration. Hepatology. 2007;45:1250–60.CrossRefPubMed
Metadaten
Titel
Adult bone marrow cells can differentiate into hemopoietic cells and endothelial cells but not into other lineage cells in normal growth and normal life
verfasst von
Seiji Yanai
Yasushi Adachi
Ming Shi
Akio Shigematsu
Chieko Shima
Yuichiro Imai
A-Hon Kwon
Susumu Ikehara
Publikationsdatum
01.03.2010
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 2/2010
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-009-0479-y

Weitere Artikel der Ausgabe 2/2010

International Journal of Hematology 2/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.